Publications
NIBIOs employees contribute to several hundred scientific articles and research reports every year. You can browse or search in our collection which contains references and links to these publications as well as other research and dissemination activities. The collection is continously updated with new and historical material.
2025
Authors
Eirik Gottschalk Ballo William J. D’Andrea Helge Irgens Høeg Kjetil Loftsgarden Manon Bajard Sabine Eckhardt Massimo Cassiani Nikolaos Evangeliou Jostein Bakke Kirstin KrügerAbstract
No abstract has been registered
Authors
Paul Eric Aspholm Carmen Rizzo Gabriella Caruso Giovanna Maimone Luisa Patrolecco Marco Termine Marco Bertolino Stefania Giannarelli Alessandro Ciro Rappazzo Josef Elster Alessio Lena Maria Papale Tanita Pescatore Jasmin Rauseo Rosamaria Soldano Francesca Spataro Maurizio Azzaro A Lo GiudiceAbstract
No abstract has been registered
Authors
Daniel James Sargent Matteo Buti Stefan Martens Claudio Pugliesi Kjersti Aaby Dag Røen Chandra Bhan Yadav Felicidad Fernández Fernández Muath K Alsheikh Jahn Davik R. Jordan PriceAbstract
No abstract has been registered
Authors
David Chludil Jaroslav Čepl Arne Steffenrem Jan Stejskal Christi Sagariya Torsten Pook Silvio Schueler Jiří Korecký Curt Almqvist Debojyoti Chakraborty Mats Berlin Milan LstibůrekAbstract
No abstract has been registered
Authors
Lucía D. Moreyra Alfonso Susanna Juan Antonio Calleja Jennifer R. Ackerfield Turan Arabacı Carme Blanco-Gavaldà Christian Brochmann Tuncay Dirmenci Kazumi Fujikawa Mercè Galbany-Casals Tiangang Gao Abel Gizaw Seid Iraj Mehregan Roser Vilatersana Juan Viruel Bayram Yıldız Frederik Leliaert Alexey P. Seregin Cristina RoquetAbstract
No abstract has been registered
Abstract
No abstract has been registered
Abstract
No abstract has been registered
Abstract
No abstract has been registered
Abstract
No abstract has been registered
Authors
Monica Sanden Eirill Ager-Wick Johanna Eva Bodin Nur Duale Anne-Marthe Ganes Jevnaker Kristian Prydz Volha Shapaval Ville Erling Sipinen Tage ThorstensenAbstract
The Norwegian Scientific Committee for Food and Environment (VKM) has assessed an application for approval of soy leghemoglobin produced from genetically modified Komagataella phaffii for food uses in the EU. In accordance with an assignment specified by the Norwegian Food Safety Authority (NFSA) and the Norwegian Environment Agency (NEA), VKM assesses whether genetically modified organisms (GMOs) intended for the European market can pose risks to human or animal health, or the environment in Norway. VKM assesses the scientific documentation regarding GMO applications seeking approval for use of GMOs as food and feed, processing, or cultivation. The EU Regulation 1829/2003/EC (Regulation) covers living GMOs that fall under the Norwegian Gene Technology Act, as well as processed food and feed from GMOs (dead material) that fall under the Norwegian Food Act. The regulation is currently not part of the EEA agreement or implemented in Norwegian law. Norway conducts its own assessments of GMO applications in preparation for the possible implementation of the Regulation. In accordance with the assignment by NFSA and NEA, VKM assesses GMO applications during scientific hearings initiated by the European Food Safety Authority (EFSA), as well as after EFSA has published its own risk assessment of a GMO, up until EU member countries vote for or against approval in the EU Commission. The assignment is divided into three stages. Soy leghemoglobin produced from genetically modified Komagataella phaffii This application is submitted to gain authorisation for the use of soy leghemoglobin (the liquid preparation is referred to as “LegH Prep”) produced from genetically modified Komagataella phaffii (yeast) as a flavouring (“meaty taste”) in meat analogue products that will be marketed in the European Union (EU). Soy leghemoglobin is intended for addition to meat analogue products that are for use in foods such as burgers, meatballs, and sausages. Komagataella phaffii-strain employed in the production of soy leghemoglobin contains genetic modifications which allow it to express this protein. Following fermentation, the cells are lysed, and the soy leghemoglobin is concentrated by physical means. The soy leghemoglobin is delivered in a liquid preparation (LegH Prep) that is standardised to contain up to 9% soy leghemoglobin on a wet weight basis and a soy leghemoglobin protein purity of at least 65%. The remainder of the protein fraction in the LegH Prep is accounted for by residual proteins from the Komagataella phaffii production strain. These residual proteins are all endogenous to Komagataella phaffii as the gene coding for the expression of soy leghemoglobin is the only gene from a different organism. VKM has assessed the documentation in application EFSA-GMO- NL-2019-162 and EFSA's scientific opinion for the use of soy leghemoglobin produced from genetically modified Komagataella phaffii. The scientific documentation provided in the application is adequate for risk assessment, and in accordance with the EFSA guidance on risk assessment of genetically modified microorganisms for use in food or feed. The VKM GMO Panel does not consider leghemoglobin from genetically modified Komagataella phaffii to imply potential specific health risks in Norway, compared to EU-countries. The EFSA opinion is adequate also for Norwegian considerations. Therefore, a full risk assessment was not performed by VKM. About the assignment: (...)